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A quality-of-life study was carried out to test the hypothesis that melanoma patients treated with a 3-cm margin of
excision suffer greater impairment of their quality of life than those treated with a 1-cm margin. The secondary aim
was to determine the predictors of a poor patient perception of their excision scar. A postal questionnaire study
was carried out using Hospital Anxiety and Depression (HAD), Psychosocial Adjustment of Illness Scale–Self-
Report (PAIS-SR), Medical Outcomes Survey–Short Form 36 (MOS-SF36), and the Cassileth Scar questionnaires.
Data were collected from 426 of the 537 patients who were mailed the questionnaires (response rate 79%). Fourteen
percent had clinically signiﬁcant anxiety and 5% had signiﬁcant depression. A poor attitude toward quality of
health care was associated with youth. Patients treated with a 3-cm margin excision had signiﬁcantly poorer mental
and physical function 1 mo after surgery, which disappeared within 6 mo. The greater difﬁculties experienced by
the 3-cm margin group were particularly in their domestic, sexual, and social roles. Women, younger patients,
those with poor physical and mental function after surgery, and those treated by a 3-cm margin were more likely to
report a poorer perception of their scar. The poorer scar perception of patients in the 3-cm group persisted
throughout the study period. Use of a 3-cm margin of excision for melanoma is associated with signiﬁcantly more
morbidity than use of a 1-cm margin, but this effect disappears in 6 mo. Patients treated by 3-cm excision were
more likely, however, to have a persistent poor view of their scar. Youth and being female were also predictors of
poor perception of the scar.
Key words: scar/HAD/PAIS-SR/MOS-SF36
J Investig Dermatol Symp Proc 9:152 –159, 2004
Cutaneous melanoma presenting with a Breslow thickness
of 2 mm or thicker is associated with a significant risk of
recurrence, locoregionally or in distant viscera (Balch et al,
2001a). The treatment is surgical, but there are as yet no
proven adjuvant therapies. The margin of excision chosen
has changed over the years. An early pathologic study
produced evidence of micrometastases in the skin around a
tumor (Sampson, 1907) and led to the use of wide excision
margins in an attempt to control a form of cancer, which at
times appeared capricious. The use of wide margins with
excision of fat down to fascia became the norm, and
margins of many inches necessitated the use of grafts.
In more recent years a view has evolved that these large
excision margins might be unnecessary. Nevertheless,
although there have been several randomized clinical trials
for thinner melanomas, providing reasonable evidence that,
in these patients, margin has no effect on survival (Veronesi
and Cascinelli, 1991), there are few data on outcome for
thicker tumors. A study published by Balch et al compared
2-cm margins with 4-cm margins (Balch et al, 1995, 2001a,
b), but only 213 patients in this trial had melanomas of 2 mm
or thicker. A randomized clinical trial comparing 1-cm
margins with 3-cm margins in melanomas 2 mm or thicker
was therefore designed. These same margins were pre-
viously compared by the WHO Melanoma Group for
melanomas thinner than 2-mm Breslow thickness (Veronesi
et al, 1988; Veronesi and Cascinelli, 1991). In this WHO trial,
margin of excision had no effect on disease-free survival or
overall survival. Five patients in the 1-cm-margin group,
however, had a local or in transit recurrence compared to
one in the 3-cm-margin group. This difference was not
statistically significant. The hypothesis to be tested in our
MSG/BAPS UK Melanoma Excision Trial was that margin of
excision has no effect on disease-free survival or overall
survival, but that there may be an increased risk of local
recurrence in the 1-cm-margin group. This MSG/BAPS UK
Melanoma Excision Trial has shown that use of a 1-cm
margin of excision for thick melanomas is associated with
a higher risk of locoregional recurrence (particularly of
regional lymph node recurrence) (M. Thomas et al, NEJH
Abbreviations: HAD, Hospital Anxiety and Depression; MCS,
mental component summary; MOS-SF36, Medical Outcomes
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in press, Feb. 2004). Although there is currently no
significant evidence that there is any effect on survival,
until the data have been allowed to mature, these data
suggest that use of a 1-cm excision margin is untenable.
These data are in press elsewhere (M. Thomas et al, NEJM
Feb. 2004), and the quality-of-life (QOL) component of the
study is reported here.
The treatment of melanoma is inevitably associated with
a scar, but the nature of the scar depends very much on the
margin of excision. A 1-cm margin can usually be carried
out under local anesthetic as an outpatient and can be
closed by primary intention. A 3-cm margin is much more
likely to require a graft as an inpatient, with a cosmetic result
surgeons would view as less satisfactory. Our hypothesis
was therefore that use of a 3-cm margin of excision would
be associated with a worse effect on QOL. It was predicted
that this effect on QOL would be measurable in terms of the
effect on physical measures and emotional measures. It
was also predicted that the perception of the cosmetic
appearance of the scar would be poorer in the 3-cm-margin
group.
A postal QOL study was performed to test this hypo-
thesis in a sample of the patients who were randomly
assigned to the MSG/BAPS UK Melanoma Excision Trial.
Results
A total of 672 questionnaires were sent to 291 prospective
subjects over a period of 2 y after surgery, and data were
collected from 240 of these subjects. Data were not
collected from 50 subjects as a result of patient refusal
and from 1 subject as a result of consultant refusal.
A total of 246 questionnaires (i.e., 1 per patient) were sent
to the retrospective patients, and data were collected from
186 of these patients. Fifty-nine patients declined to
participate, and 1 patient was excluded because of con-
sultant refusal.
There was significantly more nonresponse from retro-
spective than prospective participants over all time points,
with 24% (60/246) and 15% (101/672) of questionnaires
not returned, respectively (chi-square test, p¼0.001).
Altogether 288 patients were measured only once, 186 of
whom were in the retrospective group (Table I). Overall, the
age of responders was similar to that of those who refused
to take part and there were slightly more women in this
group (Table II).
Of the 757 questionnaires returned, there were 82
missing PCS and MCS scores, 27 missing scar scores,
and between 28 and 252 missing observations over all PAIS
domain scores. The missing PAIS domain scores related
mainly to vocational and sexual function. That is that when
patients were retired they indicated as such on the form and
left the section blank. Patients who were not sexually active
generally speaking indicated as such on the form and left
the section blank. Three patients had no scar site data and
98 patients did not have a scar score measured at 6 mo
or after.
The mean age of the study population was 62.2 y and
57% of the study population were men. Significantly more
women than men had an exposed scar, 48% (89/185) and
18% (43/241), respectively (chi-square test, po0.0001).
This was expected, because melanoma is more common
on the legs in women.
Fourteen percent (61/426) had scores consistent with
a significant degree of anxiety and an additional 18.8%
(80/426) of patients had a HAD score suggestive of
borderline anxiety. Five percent (20/426) of patients had
scores consistent with a significant degree of depression at
one time point or more and 7.7% (33/426) were possibly
depressed at one time point or more. This result concurs
with evidence that, in cancer patients, clinical anxiety is
more often present than depression (Skarstein et al, 2000).
Correlation between the different QOL measures was
assessed as an internal validation of these measures. The
weakest pairwise correlation was between PCS and MCS
(correlation coefficient, 0.05; p¼ 0.17). This was expected
because PCS and MCS were constructed to make the
distinction between physical and mental health outcomes
(Ware et al, 1994).
The following seven scores appear to be particularly
intercorrelated: HAD Depression, HAD Anxiety, Psychologi-
cal Distress (PAIS), MCS, Vocational Role (PAIS), Domestic
Role (PAIS), and Social Role (PAIS). The strongest correla-
tion of all the variables was between HAD Anxiety and PAIS
Psychological Distress (coefficient, 0.75; po0.0001). HAD
Anxiety was also highly correlated with MCS (coefficient,
0.62; po0.0001), a result that has been demonstrated
previously (Fossa and Dahl 2002). Psychological Distress
was most strongly correlated with MCS (coefficient, 0.66;
po0.0001) and HAD Depression was most strongly
correlated with Psychological Distress (coefficient, 0.65;
po0.0001). HAD Depression was also strongly correlated
with Social Role (coefficient, 0.64; po0.0001). Within the
Table I. The number of questionnaires returned at each time point by treatment group and the number of nonresponders at
each time point
o1 mo 1 mo 3 mo 6 mo 1 y 2 y Retrospective Total
1-cm margin 6 73 55 64 54 35 94 381
3-cm margin 11 64 56 67 52 34 92 376
Responders 17 137 111 131 106 69 186 757
Nonresponders (% of total) 0 (0) 30 (18) 15 (12) 19 (13) 23 (18) 14 (17) 60 (24) 161
Total number sent questionnaires
at each time point
17 167 126 150 129 83 246 918
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PAIS domains there were strong correlations between
Domestic Role and Vocational Role (coefficient, 0.69;
po0.0001), and between Domestic Role and Social Role
(coefficient, 0.69; po0.0001).
PCS and MCS The PCS and MCS scales computed using
the MOS-SF36 as overall measures of physical and mental
well-being correlated well with other measure of QOL as
described above. Both the PCS and the MCS were
significantly lower at 1 mo among the wide margin group
than the narrow margin group (Mann–Whitney U tests,
p¼0.03 and p¼0.008, respectively). The mean PCS and
MCS were somewhat lower among the wide margin group
overall, but these results were not statistically significant
at the 5% level (p¼0.06 and p¼ 0.15, respectively). A low
PCS score was associated with patients of older ages
(po0.0001) and a low MCS score was associated with
patients of younger ages (p¼ 0.001). The mean PCS and
MCS did not differ with sex or with respect to whether the
scar was exposed or not.
To determine whether the effect of time on the PCS and
MCS differed between margin groups, random effects
models were used incorporating time as a continuum in
years and an interaction term between margin and time
(Table III). These models showed that the PCS scores
improved at a significantly faster rate for the wide margin
group compared to the narrow margin group (p¼0.005), the
wide margin group having worse scores initially. The pattern
is similar but less marked for the MCS scores (the
interaction is not significant, p¼0.11).
To illustrate this, Figs 2 and 3 describe the change in the
mean PCS and MCS score for each margin group over time.
There was a large improvement in PCS score (Fig 1) among
the wide margin group between 3 and 6 mo, and from 6 mo
onward there appears to be little difference between the
treatment groups (Mann–Whitney U test for difference at 2 y,
p¼0.85). The narrow and wide margin groups never quite
reached the UK general sample PCS mean throughout the
2 y. Figure 3 shows the lower mean MCS score among the
wide margin group at 1 mo and an obvious improvement in
MCS score for the wide margin group between 1 and 6 mo.
Like the PCS score there was little difference in MCS score
between the treatment groups from 6 mo onward (Mann–
Whitney U test for difference at 2 y, p¼ 0.63). The narrow
margin group had a higher mean MCS than the UK general
sample throughout the 2 y, but the wide margin group
reached the UK general sample mean after only 3 mo. At
one time point or more: 8% of subjects had an MCS less
than 2 SD below the UK mean and 11% had a PCS less
than 2 SD below the UK mean (in each case significantly
more than 2.5%).
Paired t tests were carried out between the first and last
scores for patients measured at least twice. Subjects were
included if they had a first score in the first 3 mo and a last
score at 6 mo or later. There were no significant differences,
among the narrow margin group, between the first and last
mean PCS scores (p¼ 0.15; mean difference, 1.88; 95%
CI, 4.47 to 0.71) or between the first and last mean MCS
scores (p¼0.98; mean difference, 0.03; 95% CI, 2.19 to
2.14). Nevertheless, among the wide margin group, the first
mean PCS score was significantly lower than the final mean
PCS score (po0.0001; mean difference, 7.44; 95% CI,
10.64 to 4.24). Likewise, the first mean MCS score
Table II. Number of responders and nonresponders by age,
sex, and margin
Margin (cm)
Responders
(n¼426)
Nonresponders
(n¼ 111)
1 3 1 3
N 216 210 53 58
Mean age,
years (SD)
61.2 (14.0) 62.1 (14.4) 60.4 (15.2) 58.5 (18.3)
% men 59.3 53.8 45.3 39.7
Table III. Random effects models for PCS and MCS including timea
Covariates
PCS (model 1) MCS (model 2)
Coefﬁcient (SE) p value Coefﬁcient (SE) p value
Marginb 157.0 (83.5) 0.06 133.1 (91.6) 0.15
12 moc 29.3 (82.7) 0.72 67.7 (87.3) 0.44
6 moc 21.5 (77.6) 0.78 71.7 (82.0) 0.38
3 moc 297.2 (83.9) o0.0001 52.3 (89.0) 0.56
1 moc 559.2 (80.3) o0.0001 241.6 (85.3) 0.005
o1 moc 617.8 (187.4) 0.001 235.0 (197.6) 0.23
Sexd 58.2 (90.4) 0.52 61.5 (99.1) 0.54
Age 11.1 (2.94) o0.0001 11.2 (3.2) 0.001
Exposede 66.6 (97.1) 0.49 55.7 (106.5) 0.60
aNumber of observations, 673; number of subjects, 392. PCS and MCS are squared; a lower score indicates a worse outcome.
b3-cm margin compared with the baseline of 1-cm margin.
cThe baseline of the time variable is 2 y.
dWomen compared with the baseline of men.
eExposed scar compared with the baseline of not exposed.
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was significantly lower than the final mean MCS score
among the wide margin group (p¼0.02; mean difference,
2.63; 95% CI, 4.74 to 0.52).
PAIS domains
Health-Care Orientation (PAIS domain 1) and Psychological
Distress (PAIS domain 7) Mann–Whitney U tests at 1 mo
showed no differences between the narrow and the wide
margin groups with respect to psychological distress or
attitude toward the quality of medical care, treatment, and
their illness (as measured using PAIS Health-Care Orienta-
tion). A poor attitude toward the quality of medical care was
associated with younger age overall (po0.0001), but there
was no effect of sex or whether the scar was exposed.
Overall, the wide and narrow margin groups did not differ
in their attitude toward the quality of medical care, to
treatment and to their illness (p¼0.4). Overall, there was no
evidence of a significant change in these attitudes over time
and no difference in change of attitudes between treatment
groups over time (interaction term, p¼0.88).
Results for the Psychological Distress domain (PAIS 7)
were in all respects very similar to those for the MCS score,
with which this domain is highly correlated.
PAIS domain 2 through PAIS domain 6 Chi-square tests
between the binary PAIS domains and margin size at each
time point revealed the following results: significantly more
problems among the wide margin group in domestic role
and sexual role at 1 mo (chi-square (1), 7.17; p¼0.007; and
chi-squared (1), 6.35; p¼0.01, respectively); significantly
more problems among the wide margin group in social
role at 1 and 3 mo (chi-square (1), 7.21; p¼0.007; and chi-
square (1), 5.52; p¼ 0.02, respectively). There were no
significant differences in vocational role and extended
family relations between treatment groups at any time point.
Results of the generalized estimating equation models
are shown in Table IV. Overall, there were significantly
reduced odds of having poor adjustment to domestic role
over time in the narrow margin group (OR of 0.43 for each
year that passes) but not of the other domains. The chance
of improvement in domestic role over time was significantly
higher among the wide margin group than the narrow
margin group (OR, 0.43  0.51¼ 0.22, test for interaction;
p¼0.05). Thus patients with a wide margin were more likely
to find their domestic role a problem, but this was more
likely to improve. There were significantly reduced odds of
poor adjustment to social role over time among the wide
Figure 1
MSG/BAPS trial.
Figure 2
Change in mean PCS over time, by margin group.
Figure3
Change in mean MCS over time, by margin group. Scores measured
at less than 1 mo were not incorporated into the graphical displays
because of small numbers.
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margin group only (OR, 0.37, interaction term; p¼ 0.03), and
social role was two to three times more likely to be
adversely affected in those with a scar on an exposed site.
HAD Depression and Anxiety scores Results for both of
these scores were similar to those for the MCS score, with
which they are highly correlated, except that the depression
score showed no relationship with age.
Cassileth Scar score Women were found to have a poorer
perception of their scar overall than males (po0.0001)
(a result that has been demonstrated previously (Cassileth
et al, 1983)), as did patients who were younger (po0.0001)
or who had an exposed scar (p¼0.001). The wide margin
group had a significantly poorer perception of their scar
than the narrow margin group, and unlike the other QOL
measures, this difference persisted over the whole period of
follow-up. The scar scores were 19% lower in the wide
margin overall (po0.0001; 95% CI, 15%–23%), 22% lower
at 1 mo (po0.0001; 95% CI, 13%–30%) and 16% at 2 y
(po0.0001; 95% CI, 10%–21%). Overall, these problems
reduced significantly between 1 and 6 mo and 2 y, and the
wide margin group improved at a significantly faster rate
than the narrow margin group (interaction term, p¼ 0.02).
Figure 4 illustrates this pattern over time. There was a
significant correlation between the scar score and the HAD
Depression score at all time points from 1 mo, ranging from
0.45 at 1 mo to 0.33 at 2 y (Pearson correlations). A poor
scar score was therefore held to be clinically significant.
The predictors of a poor scar score between 6 mo and 2 y
after surgery Table V shows the effect of initial PCS and
MCS scores on whether or not a patient had a poor scar
score at their final assessment (6 mo to 2 y after surgery) in
those measured at least twice. The PCS and MCS scores
were classified into approximate quartiles based on all time
points. Patients in the lowest quarter of PCS scores initially
were 4.5 times more likely to have a poor scar score than
patients in the highest quarter (p¼0.04). Patients with a first
MCS score less than the median were between three and
four times more likely to have a poor scar score than
patients in the baseline category. This suggests that
increased physical and mental limitations at the first time
point were associated with an increased risk of a poor scar
score at the last assessment (6 mo to 2 y after surgery).
Similarly for psychological distress, extended family, and
vocational role, subjects in the highest category (poorer
adjustment to illness) were more likely to have a poor scar
score than patients in the baseline category. There were no
associations for the remaining PAIS domains or for the HAD
scales.
Discussion
This was a postal questionnaire study of a sample of
patients recruited to the first UK national surgical melanoma
trial. Responses were received from 83% of patients sent
questionnaires in the prospective study, and 76% of
patients contacted from the retrospective study (79%
overall). Of the 918 questionnaires sent out in total, 757
Table IV. Generalized estimating equation models for PAIS domain 2 through PAIS domain 6
Parameter
Domaina
Vocational Domestic Sexual Extended family Social
No. of observations 504 652 568 713 706
Marginb 1.66 (0.68–4.08) 3.11 (1.17–8.27) 1.92 (0.70–5.31) 1.09 (0.43–2.75) 4.22 (1.54–11.55)
Time in years 0.69 (0.44–1.06) 0.43 (0.27–0.68) 1.35 (0.84–2.15) 0.81 (0.52–1.27) 0.78 (0.51–1.21)
Margin  Time 0.67 (0.36–1.24) 0.51 (0.26–1.00) 0.60 (0.30–1.19) 0.93 (0.49–1.77) 0.48 (0.25–0.92)
Sexc 0.66 (0.36–1.22) 1.52 (0.75–3.08) 0.57 (0.26–1.27) 0.68 (0.32–1.42) 0.67 (0.33–1.39)
Age 0.98 (0.96–1.00)d 0.98 (0.95–1.00)d 1.02 (0.99–1.04) 1.00 (0.98–1.03) 1.00 (0.97–1.02)
Exposedd 1.82 (0.94–3.53) 1.21 (0.57–2.54) 1.43 (0.61–3.32) 1.04 (0.48–2.26) 2.55 (1.17–5.56)
OR (95% CI). Odds ratios relate to risk of a poor outcome. Results significant at the 5% level are bolded.
a3-cm margin compared with the baseline of 1-cm margin.
bWomen compared with the baseline of males.
cExposed scar compared with the baseline of not exposed.
dp values are 0.09 for vocational role and 0.06 for domestic role.
Figure4
Change in mean scar score with time in the two treatment groups.
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(82%) were returned. Only one-third of the participants
(138/426) returned multiple questionnaires. Analyses per-
formed on the data collected from patients who returned
multiple questionnaires were consistent with the results
from the whole data set.
The study used a series of well-described QOL mea-
sures, and good correlation was found between measures
purporting to measure similar things. For example, there
was strong correlation between HAD Anxiety, MCS, and
Psychological Distress. We found the MOS-SF36 item
questionnaire summary variables MCS and PCS useful in
monitoring changes over time, and the PAIS domains were
useful for looking at specific issues such as attitudes to the
health-care services.
The HAD questionnaire showed significant levels of
anxiety in the melanoma patients as was expected, but
the MOS-SF36 item MCS score for mental health showed
that the population of melanoma patients reached UK
population means for mental function 3 mo after surgery.
Overall then, the trauma of surgery for melanoma (and
presumably the trauma of dealing with a diagnosis of
cancer) was associated with measurable anxiety, but
adjustment was made such that population means were
reached in a comparatively short period of time. This
adjustment took no account of relapse during the course of
the study, which might have been expected to increase
anxiety again. It is of note that lower MCS scores indicative
of poorer mental health were associated with younger age
at diagnosis.
It is of interest that a poorer attitude toward the quality of
medical care was associated with younger age, and one
could speculate whether this was a function of age or was a
cohort effect reflecting changes in society generally. It did
not differ according to margin of excision, sex, or whether or
not the scar was exposed, which might suggest that the
specific experiences of the patient were less important than
their age.
The purpose of the study was to investigate the effect
of margin of excision on QOL. The MSG/BAPS UK mela-
noma excision trial itself (M. Thomas et al, NEJM Feb. 2004,
TableV. Logistic regression models for the last scar score, including PCS and MCS, in subjects measured at least twice:
a multivariate modela
Last scar score N OR (95% CI) p value
PCS
1 (PCS455.4) 25 1
2 (49.9oPCS¼55.4) 31 1.37 (0.32–5.84) 0.67
3 (39oPCS¼49.9) 33 2.30 (0.57–9.25) 0.24
4 (PCS¼39) 39 4.45 (1.11–17.93) 0.04
Sexb (male/female) 72/56 3.91 (1.40–10.94) 0.009
Agec (y)
53 40 1
53o69 47 0.30 (0.10–0.88) 0.03
469 41 0.05 (0.01–0.20) o0.0001
Exposedc (not exposed/exposed) 86/42 0.62 (0.20–1.92) 0.41
Margind (1 cm/3 cm) 64/64 6.29 (2.28–17.38) o0.0001
MCS
1 (MCS459.1) 32 1
2 (55.3oMCS¼59.1) 31 1.77 (0.41–7.58) 0.44
3 (46.9oMCS¼55.3) 33 4.27 (1.01–18.07) 0.05
4 (MCS¼46.9) 32 3.28 (0.80–13.39) 0.11
Sexb (male/female) 72/56 4.00 (1.44–11.12) 0.008
Age (y)
Baseline (age¼53) 40 1
53o69 47 0.37 (0.13–1.09) 0.07
469 41 0.07 (0.02–0.27) o0.0001
Exposedc (not exposed/exposed) 86/42 0.97 (0.33–2.89) 0.96
Margind (1 cm/3 cm) 64/64 5.55 (2.06–14.98) 0.001
aNumber of subjects, 128.
bWomen compared with the baseline of men.
cExposed scar compared with the baseline of not exposed.
d3-cm margin compared with the baseline of 1-cm margin.
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in press) showed that use of a 3-cm margin of excision was
associated with longer hospital stay, greater use of skin
grafts, and higher surgical complication rates. Not surpris-
ingly then, in this QOL study, use of a 3-cm margin was
associated with significantly greater impairment of physical
function, which took 3 to 6 mo to settle, and this impairment
was greater in older individuals. The larger margin was
associated, in addition, with a significant but less marked
effect on mental function as measured using the MCS
(SF-36 item). The PAIS domains allow the investigator to
look at specific aspects of life. Use of the 3-cm margin was
significantly more likely to have an adverse effect on the
patient’s function in the home, sexually and socially at 1 mo.
But these functions (particularly at home and socially)
improved with time.
Poorer perceptions of the surgical scar, as measured
using the Cassileth Scar questionnaire were significantly
more likely in the 3-cm margin group, even at 2 y after
surgery. At 2 y , the degree of physical and mental health
impairment associated with wider excision margins, as
measured by mean questionnaire scores, settled. The
implication is therefore that patients who have had wider
excision margins view their scar as poorer at 2 y but the
degree of physical and mental distress associated with that
is not detectable with MOS-SF36 in the group overall. The
correlation of poor scar scores with HAD Depression scores
at all time points, however, suggests that poor perception of
the scar was clinically relevant.
A poor perception of the scar was more likely in women
and younger patients as was predicted, but whether or not
the scar was exposed had no effect. Patients who had low
PCS scores when first measured were more likely to
perceive their scar to be poor. Patients whose graft does
not take, or who have sepsis, are more likely to be
physically impaired around the time of surgery. They are
more likely also to have a poorer scar, which may explain
this correlation. It is not possible for us to distinguish this
from a general effect of depression, however, and indeed a
low MCS score was also indicative of a poor perception of
the scar.
This study showed significantly greater impairment of
physical and mental components of QOL after 3-cm
margins of excision rather than after 1-cm margins in mela-
noma patients. Nevertheless, with the exception of percep-
tion of their scar site, there were no persisting differences in
these measures 2 y after surgery. Use of a wider excision
margin was associated with a persistently poorer percep-
tion of the scar.
The excision trial has to date shown a greater loco-
regional relapse rate if a 1-cm margin is used albeit with not
yet significantly increased mortality (M. Thomas et al, NEJM
Feb. 2004, in press). The choice for the patient and his/her
doctor therefore involves a balance between poorer scars
with attendant, albeit transient greater morbidity, and an
increased risk of a lymph node dissection if a 1-cm margin
is used rather than a 3-cm margin.
Materials and Methods
Patients A total of 900 patients were recruited to the MSG/BAPS
UK Melanoma Excision Trial (in press, NEJM). These patients were
informed about the QOL study by surgeons randomizing to the
margins trial, who sought permission for a postal consent process
to be carried out by a study coordinator based in Leeds. The QOL
component of the trial was funded for only 2 of the 8 y in which the
excision trial was running. During this period, 685 English-speaking
subjects were identified either at the time of randomization to the
MSG/BAPS UK Melanoma Excision Trial or as having being
randomized previously. Of the 685 subjects, 348 were identified
at the time of randomization (the prospective group) and 337 were
identified after randomization (the retrospective group). Of 348
prospective subjects 291 were asked by post to consent to
completion of a series of questionnaires from diagnosis for a
period of 2 y, and 246 of 337 retrospective subjects were asked to
complete a single set of questionnaires 2 y or more after surgery.
The main reasons for not posting consent forms and question-
naires to the remaining patients identified were patient death
(n¼ 93) or consultant refusal (n¼ 35) (Fig 1).
The questionnaires chosen were the Hospital Anxiety and
Depression (HAD), Psychosocial Adjustment of Illness Scale–
Self-Report (PAIS-SR), Medical Outcomes Survey–Short Form 36
(MOS-SF36), and the Cassileth Scar score as described below. All
four questionnaires were sent to patients at each time point. The
original protocol stipulated that a set of questionnaires would be
given to the patient by the randomizing surgeon at surgery and that
the other five sets would be dispatched at 1 mo, 3 mo, 6 mo, 1 y,
and 2 y after surgery. Nevertheless, few patients were given the
questionnaires by the randomizing surgeon (17 in all) at time point
1. Losses of patients from the study occurring as a result of patient
illness, death, or withdrawal from the study are indicated by falling
numbers of questionnaires dispatched in Table I.
QOL measures
HAD scale The HAD scale was developed to screen for significant
anxiety and depression in patients with physical illness, using two
subscales (HAD Anxiety and HAD Depression). The HAD Anxiety
and the HAD Depression scales each consist of seven items,
scored from 0 (no problems) to 3 (maximum distress), resulting in
total scores ranging from 0 to 21. It is suggested that scores
between 8 and 10 indicate ‘‘possible cases’’ and scores of
11þ indicate ‘‘cases’’ of anxiety and depression (Skarstein et al,
2000; Fossa and Dahl, 2002).
PAIS-SR The PAIS-SR questionnaire was designed to assess the
quality of a patient’s psychosocial adjustment to a current medical
illness or its resultant effects. The PAIS-SR consists of seven
domains, which have been identified as having high predictive
relevance for adjustment to illness. These domains relate to health-
care orientation (perception of services), vocational environment,
domestic environment, sexual relationships, extended family
relationships, social environment, and psychological distress. A
total of 46 items encompass the Seven domains, each item being
scored on a 4-point scale with alternated scale direction on the
even-numbered items to reduce position response biases (Dero-
gatis, 1983). A high PAIS domain score indicates poor adjustment.
MOS-SF36 The MOS-SF36 is a 36-item questionnaire assessing
health function (Ware et al, 1994). It consists of eight scales:
physical functioning, vitality, social functioning, general health,
bodily pain, physical role, emotional role, and mental health (Ware
et al, 1994). The eight MOS scales were aggregated, using the US
scoring algorithm, to produce a physical component summary
(PCS) scale and a mental component summary (MCS) scale. It has
been shown that the correlations between summary scales using
the UK-specific algorithms and those using the US algorithms are
sufficiently high to justify using the US scoring algorithms, which
are well documented and the most widely used (Ware et al, 1998).
A low PCS score indicates substantial limitations in self-care,
physical and social activities, severe bodily pain, and frequent
tiredness. A low MCS score indicates frequent psychological
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distress and substantial social disability owing to emotional
problems (Ware et al, 1994).
Cassileth Scar score The Cassileth Scar score questionnaire was
developed to investigate patients’ opinions of the size and
cosmetic implications of their excisions (Cassileth et al, 1983).
The questionnaire contains 12 items, each scored from 1 (minimal
negative cosmetic impact) to 4 (maximum negative cosmetic
impact). The questionnaire also contains front and back outline
drawings of the human body, on which patients were asked to
indicate the size, shape, and location of their scar. From this, a scar
site variable was calculated and grouped into the following four
categories: trunk, upper arm/leg, head, or lower arm/leg. An
additional variable was calculated based on whether or not a
patient’s scar was predicted to be usually exposed, and this was
coded as follows: 0¼ trunk or upper arm/leg; 1¼ head or lower
arm/leg.
Statistical methods Spearman’s rank correlation coefficients
were produced for all pairwise combinations of the untransformed
MCS, PCS, PAIS, HAD, and scar score variables.
The frequency distributions of MCS and PCS were left skewed,
so squaring transformations were used to normalize the data. Log
transformations were used for the right-skewed frequency dis-
tributions of HAD, PAIS domain 1, PAIS domain 2, and the scar
scores (adding one to the scores before log transformation). Mann–
Whitney U tests were carried out to identify possible differences in
these scores between the two margin groups at particular time
points, and random effects models were used to examine the
distribution of these scores over time for each margin group.
Graphs of the mean MCS, PCS, and scar scores at each time
point were used to display changes over time. As a comparative
measure, the graphs also display the corresponding means and
standard deviations from data collected on a sample of 1760 UK
subjects by means of a general population survey (also calculated
using the US scoring algorithms) (Ware et al, 1998).
Two-thirds (288/426) of patients had only completed one
questionnaire so graphs of the mean MCS and PCS scores at
each time point were also plotted for the 138 patients who were
measured at least twice. This was to ascertain that any improve-
ments in the mean MCS or PCS scores over time were due to
changes within patients rather than differences between patients.
In addition, for patients measured at least twice, paired t tests were
carried out between their first and last PCS scores and between
their first and last MCS scores, for each margin group.
For PAIS domain 2 through 6, log transformations did little to
normalize the data because at least one-third of all the observa-
tions were zero. On this basis, a binary variable was calculated for
PAIS domain 2 to PAIS domain 6, and these variables were
analyzed by means of generalized estimating equation logit
models.
The random effects and generalized estimating equation
models examined the effect of treatment margin and how this
changed over time and were adjusted for age, sex, and whether a
patient’s scar was exposed or not. Models including interaction
terms between margin and time were used to determine whether
changes in scores over time differed between margin groups.
One aim was to identify whether a poor initial HAD, PAIS, MCS,
or PCS score could predict a poor scar score at least 6 mo after
surgery. For patients whose scar score was last measured at least
6 mo after surgery, their last scar score was recorded. A binary
variable was then calculated and coded as zero for observations
in the lower two-thirds of final scores and coded as 1 for
observations in the upper one-third of final scores (poor scar).
The first MCS, PCS, HAD, and PAIS scores were then identified for
each patient, and logistic regression models were used to
determine which of the initial measures predicted a poor scar
score at least 6 mo after surgery. The analysis was carried out in
those patients whose QOL was measured on at least two
occasions. All logistic regression models adjusted for age, sex,
whether exposed, and margin size. All analyses were carried out
using Stata, version 7 (StataCorp, 2001).
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